We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

β-Blockers in Diabetic Patients With Heart Failure—Reply

Björn Pasternak, MD, PhD1; Henrik Svanström, MSc1; Anders Hviid, DrMedSci1
[+] Author Affiliations
1Department of Epidemiology Research, Statens Serum Insitut, Copenhagen, Denmark
JAMA Intern Med. 2015;175(4):657. doi:10.1001/jamainternmed.2014.8017.
Text Size: A A A
Published online


In Reply We thank Dr Santulli for his suggestions for additional analyses. We have now conducted a subgroup analysis according to history of diabetes, defined as treatment with any oral antidiabetic drug or insulin within the last year. Among patients with diabetes, the crude all-cause mortality rate was 11.0 deaths per 100 person-years among carvedilol users and 11.9 deaths per 100 person-years among metoprolol succinate users; the propensity score-adjusted hazard ratio (aHR) for all-cause mortality was 0.94 (95% CI, 0.76-1.17) comparing carvedilol vs metoprolol succinate. Among patients without diabetes, the mortality rates were 6.0 and 6.1 deaths per 100 person-years among carvedilol and metoprolol users, respectively, and the aHR was 1.00 (95% CI, 0.87-1.15). Data on history of hypertension are not available in this data set.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





April 1, 2015
Gaetano Santulli, MD, PhD
1Columbia University Medical Center, New York, New York
JAMA Intern Med. 2015;175(4):657. doi:10.1001/jamainternmed.2014.8009.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...